Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
11,32 USD | +1,07% | -1,99% | -19,32% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 633 mln. 587 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -128 mln. -119 mln. | Nettowinst (verlies) 2025 * | -162 mln. -150 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-4,87
x | K/w-verhouding 2025 * |
-4,2
x | Werknemers | 74 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 94% |
Recentste transcriptie over Olema Pharmaceuticals, Inc.
1 dag | +1,07% | ||
1 week | -1,99% | ||
Lopende maand | -8,71% | ||
1 maand | -12,72% | ||
3 maanden | -21,88% | ||
6 maanden | -12,79% | ||
Lopend jaar | -19,32% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Peter Kushner
FOU | Founder | 86 | 07-08-06 |
Sean Bohen
CEO | Chief Executive Officer | 58 | 01-09-20 |
Cyrus Harmon
FOU | Founder | 54 | 07-08-06 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ian Clark
CHM | Chairman | 62 | 01-08-20 |
J. Garland
BRD | Director/Board Member | 55 | 16-10-23 |
Andy Rappaport
BRD | Director/Board Member | 66 | 01-01-13 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.59% | 4 M€ | -5,15% | - | |
0.01% | 0 M€ | 0,00% | - | |
0.00% | 36 M€ | +4,92% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 11,32 | +1,07% | 499 221 |
27-03-24 | 11,2 | +2,28% | 458 304 |
26-03-24 | 10,95 | -0,18% | 432 189 |
25-03-24 | 10,97 | -2,32% | 659 919 |
22-03-24 | 11,23 | -2,77% | 1 128 457 |
uitgestelde koers Nasdaq, 28 maart 2024 om 21:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-19,32% | 633 mln. | |
+9,30% | 46,03 mld. | |
+52,73% | 44,55 mld. | |
+7,15% | 40,8 mld. | |
-8,78% | 28,25 mld. | |
+18,68% | 27,71 mld. | |
-21,92% | 18,82 mld. | |
+14,62% | 13,91 mld. | |
+31,85% | 12,43 mld. | |
+4,47% | 10,81 mld. |